E-LIB Suche - Ergebnisse für: Mourya, Sanchita

1

BMF-219: A Novel Therapeutic Agent to Reestablish Functiona..:

Frias, Juan P. ; Mourya, Sanchita ; Munneke, Brian...
Metabolism. 153 (2024) - p. 155884 , 2024

2

P-269: COVALENT-101: a Phase 1 study of BMF-219, a novel or..:

Ravandi, Farhad ; Carraway, Hetty ; Khouri, Jack...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S185-S186 , 2022

Link: https://doi.org/10.1016/..

3

Week 26 results from the PaTH Forward Open-Label Extension ..:

Rejnmark, Lars ; Schwarz, Peter ; Rubin, Mishaela...
Bone Reports. 14 (2021) - p. 100773 , 2021

Link: https://doi.org/10.1016/..

4

Disease Burden of Patients Living With Hypoparathyroidism: ..:

Murphy, Deborah ; Sanders, Bob ; Gulley, Loretta...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A260-A261 , 2021

Link: https://doi.org/10.1210/..

5

TransCon PTH as a Hormone Replacement Therapy for Patients ..:

Rubin, Mishaela R ; Rejnmark, Lars ; Schwarz, Peter E...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A253-A253 , 2021

Link: https://doi.org/10.1210/..

6

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlle..:

Khan, Aliya A ; Rejnmark, Lars ; Rubin, Mishaela...
The Journal of Clinical Endocrinology & Metabolism. 107 (2021) 1 - p. e372-e385 , 2021

Link: https://doi.org/10.1210/..

7

Psychometric validation of the Hypoparathyroidism Patient E..:

Brod, Meryl ; McLeod, Lori ; Markova, Denka...
Journal of Patient-Reported Outcomes. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

8

Design and topline results of TransCon PTH, a long-acting P..:

Karpf, David B. ; Mourya, Sanchita ; Khan, Aliya.
Bone Reports. 13 (2020) - p. 100351 , 2020

Link: https://doi.org/10.1016/..

9

A Randomized Double-Blind Placebo-Controlled First-In-Human..:

Karpf, David B ; Pihl, Susanne ; Mourya, Sanchita...
Journal of Bone and Mineral Research. 35 (2020) 8 - p. 1430-1440 , 2020

Link: https://doi.org/10.1002/..

10

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransC..:

Karpf, David B ; Markova, Denka ; Mourya, Sanchita...
Journal of the Endocrine Society. 4 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1210/..

11

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlle..:

Khan, Aliya A ; Rejnmark, Lars ; Rubin, Mishaela...
info:eu-repo/semantics/altIdentifier/pmid/34347093. , 2022

Link: https://hdl.handle.net/1..

12

PaTH Forward:A Randomized, Double-Blind, Placebo-Controlled..:

Khan, Aliya A ; Rejnmark, Lars ; Rubin, Mishaela...
Khan , A A , Rejnmark , L , Rubin , M , Schwarz , P , Vokes , T , Clarke , B , Ahmed , I , Hofbauer , L , Marcocci , C , Pagotto , U , Palermo , A , Eriksen , E , Brod , M , Markova , D , Smith , A , Pihl , S , Mourya , S , Karpf , D B & Shu , A D 2022 , ' PaTH Forward : A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism ' , Journal of Clinical Endocrinology and Metabolism , vol. 107 , no. 1 , pp. E372-E385 . https://doi.org/10.1210/clinem/dgab577. , 2022

Link: https://pure.au.dk/porta..

13

TransCon PTH as a Hormone Replacement Therapy for Patients ..:

Rubin, Mishaela R ; Rejnmark, Lars ; Schwarz, Peter E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090331/. , 2021

Link: http://www.ncbi.nlm.nih...

14

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlle..:

Khan, Aliya A ; Rejnmark, Lars ; Rubin, Mishaela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684498/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Psychometric validation of the Hypoparathyroidism Patient E..:

Brod, Meryl ; McLeod, Lori ; Markova, Denka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355305/. , 2021

Link: http://www.ncbi.nlm.nih...